Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04624906
Title Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia (BRAWM)
Acronym BRAWM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
Tom Baker Cancer Centre RECRUITING Calgary Alberta Canada Details
Cross Cancer Institute RECRUITING Edmonton Alberta Canada Details
Vancouver General Hospital RECRUITING Vancouver British Columbia Canada Details
QEII Health Sciences Centre RECRUITING Halifax Nova Scotia Canada Details
Hamilton Health Sciences Centre - Juravinksi RECRUITING Hamilton Ontario Canada Details
The Ottawa Hospital RECRUITING Ottawa Ontario Canada Details
Sunnybrook Health Sciences Centre RECRUITING Toronto Ontario M4N 3M5 Canada Details
CHU de Quebec - University Laval RECRUITING Laval Quebec Canada Details
McGill University Health Centre RECRUITING Montréal Quebec Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field